All You Need to Know About VistaGen Therapeutics Rating Upgrade to Buy
Vistagen Therapeutics, Inc. Common Stock · Now $0.65
+2.7% in 3d after detection
Post-detection moves
1h
—
1d
+1.5%
3d
+2.7%
7d
-0.0%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS